The Clinical Evaluation of Two Daily Disposable Contact Lenses
Status
Completed
Conditions
Myopia
Treatments
Device: etafilcon A
Device: omafilcon A
Details and patient eligibility
About
The objective of this study is to evaluate the clinical performance of two daily disposable contact lenses.
Enrollment
65 patients
Sex
All
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- They are of legal age (18 years) and capacity to volunteer.
- They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
- They are willing and able to follow the protocol.
- They would be expected to attain at least 6.9 (20/30) in each eye with the study lenses.
- They are able to wear contact lenses which have a back vertex power of -1.00 to -6.00DS.
- They have a maximum of 1.00D of refractive astigmatism (i.e. < 1.00 DC).
- They have worn soft contact lenses within six months of starting the study.
Exclusion criteria
- They have an ocular disorder which would normally contra-indicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are using any topical medication such as eye drops or ointment.
- They are aphakic.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
- They are pregnant or lactating.
- They have grade 2 or greater of any of the following ocular surface signs: corneal edema, corneal vascularization, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
- They have any infectious disease (e.g., hepatitis) or any immunosuppressive disease (e.g., HIV).
- They have diabetes.
- They are currently taking part in any other clinical study or research.
Trial design
Primary purpose
Treatment
Allocation
Randomized
Interventional model
Crossover Assignment
Masking
Single Blind
65 participants in 4 patient groups
etafilcon A/etafilcon A
Active Comparator group
Description:
Period 1: etafilcon A, Period 2: etafilcon A
Treatment:
Device: etafilcon A
etafilcon A/omafilcon A
Active Comparator group
Description:
Period 1: etafilcon A, Period 2: omafilcon A
Treatment:
Device: etafilcon A
Device: omafilcon A
omafilcon A/etafilcon A
Active Comparator group
Description:
Period 1: omafilcon A, Period 2: etafilcon A
Treatment:
Device: etafilcon A
Device: omafilcon A
omafilcon A/omafilcon A
Active Comparator group
Description:
Period 1: omafilcon A, Period 2: omafilcon A
Treatment:
Device: omafilcon A
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems